KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Humana (HUM) Capital Expenditures (2016 - 2025)

Humana (HUM) has disclosed Capital Expenditures for 16 consecutive years, with $135.0 million as the latest value for Q3 2025.

  • On a quarterly basis, Capital Expenditures changed N/A to $135.0 million in Q3 2025 year-over-year; TTM through Sep 2025 was $567.0 million, a N/A change, with the full-year FY2024 number at $575.0 million, down 42.73% from a year prior.
  • Capital Expenditures was $135.0 million for Q3 2025 at Humana, up from $114.0 million in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $329.0 million in Q2 2021 to a low of $95.0 million in Q1 2025.
  • A 4-year average of $240.8 million and a median of $279.0 million in 2022 define the central range for Capital Expenditures.
  • Peak YoY movement for Capital Expenditures: skyrocketed 51.04% in 2021, then fell 24.41% in 2023.
  • Humana's Capital Expenditures stood at $326.0 million in 2021, then dropped by 15.64% to $275.0 million in 2022, then decreased by 18.91% to $223.0 million in 2023, then plummeted by 39.46% to $135.0 million in 2025.
  • Per Business Quant, the three most recent readings for HUM's Capital Expenditures are $135.0 million (Q3 2025), $114.0 million (Q2 2025), and $95.0 million (Q1 2025).